ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CDXS Codexis Inc

3.53
0.02 (0.57%)
Last Updated: 10:12:53
Delayed by 15 minutes

Period:

Draw Mode:

Volume 22,080
Bid Price 3.52
Ask Price 3.54
News -
Day High 3.53

Low
1.45

52 Week Range

High
4.91

Day Low 3.445
Company Name Stock Ticker Symbol Market Type
Codexis Inc CDXS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.02 0.57% 3.53 10:12:53
Open Price Low Price High Price Close Price Prev Close
3.47 3.445 3.53 3.51
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
318 22,080 $ 3.48 $ 76,844 - 1.45 - 4.91
Last Trade Time Type Quantity Stock Price Currency
10:12:53 13 $ 3.53 USD

Codexis Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
243.95M 70.30M - 70.14M -76.24M -1.08 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Codexis News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CDXS Message Board. Create One! See More Posts on CDXS Message Board See More Message Board Posts

Historical CDXS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.843.8853.383.60387,114-0.31-8.07%
1 Month2.914.032.623.47526,3570.6221.31%
3 Months4.184.912.613.55554,386-0.65-15.55%
6 Months1.944.911.853.15647,6811.5981.96%
1 Year2.594.911.452.63820,1850.9436.29%
3 Years19.9242.011.4510.10775,291-16.39-82.28%
5 Years18.9942.011.4511.97630,425-15.46-81.41%

Codexis Description

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes and Novel Biotherapeutics. It generates maximum revenue from the Performance Enzymes segment.

Your Recent History

Delayed Upgrade Clock